Antidiabetic SGLT 2 Inhibitor Market Outlook: Emerging Opportunities in Diabetes Management
The rising prevalence of diabetes and increasing demand for effective glucose-management therapies are creating opportunities in the Antidiabetic SGLT 2 Inhibitor Market. SGLT2 inhibitors are a class of medicines that help manage blood glucose by promoting the removal of excess glucose through urine. The market was valued at approximately USD 3.13 billion in 2024 and is projected to reach...
0 Σχόλια 0 Μοιράστηκε 87 Views 0 Προεπισκόπηση